FDA Panel Unanimously Backs Johnson & Johnson Vaccine
A panel of experts said the agency should authorize emergency use of the single-dose vaccine that is easier to transport and store.
Read moreA panel of experts said the agency should authorize emergency use of the single-dose vaccine that is easier to transport and store.
Read moreA federal court in California declined to dismiss a suit challenging the Food and Drug Administration’s approval of the animal drug Experior, which is supposed to reduce the amount of ammonia released from cattle waste.
Read moreA single-dose vaccine candidate developed by Johnson & Johnson prevents deaths and hospitalizations, though with less efficacy than Moderna and Pfizer’s products.
Read moreThe 11th Circuit ruled that it lacks jurisdiction over patients’ appeal to intervene in an action between a corporation running a stem cell “bank” and the U.S. Food and Drug Administration, which sued the bank to prevent it from distributing stem cell products until it obtains approval.
Read moreBotanicals are essential to the creation of gin, but a class says Bombay Sapphire’s “grains of paradise” run afoul an antiquated Florida law against adulterating liquor with spices.
Read moreLawmakers say manufacturers exploited the lack of federal regulation to set dangerously high internal standards for toxic heavy metal levels.
Read moreThe Supreme Court on Tuesday granted the Trump administration ‘s request to reinstate a rule requiring women to visit a medical center to get an abortion drug, after a lower court lifted the regulation in light of the Covid-19 pandemic.
Read moreTabling concerns about second-dose supplies, the president-elect has a new strategy to combat the slow rollout of vaccines for the novel coronavirus under Trump.
Read moreThe Food and Drug Administration approved Moderna’s vaccine for Covid-19 Friday evening, making it the second vaccine authorized for use in the United States, a nation which continues to reel from the respiratory virus that has now killed over 310,000.
Read moreA second Covid-19 vaccine was recommended for emergency use by advisers to the Food and Drug Administration on Thursday, meaning distribution nationwide could start as soon as next week.
Read moreNew findings on Moderna’s Covid-19 vaccine released Tuesday confirm its high efficacy rate and could lead to imminent approval for emergency use.
Read moreThe nation’s first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans.
Read moreA committee of advisers to the Food and Drug Administration voted Thursday to recommend Pfizer’s Covid-19 vaccine for emergency use nationwide to fight the pandemic that has killed nearly 300,000 Americans since March.
Read moreThe government watchdog group American Oversight sued the Trump administration Wednesday, claiming Health and Human Services, the Federal Drug Administration and the CDC have stonewalled its requests for communications with Pfizer about a coronavirus vaccine.
Read moreA detailed analysis released by the U.S. Food and Drug Administration on Tuesday verifies the safety and efficacy of a Covid-19 vaccine developed by Pfizer, two days before a meeting to recommend the vaccine for emergency use.
Read moreThe D.C. Circuit affirmed the FDA’s ruling determining that e-cigarettes are “tobacco products” subject to regulation under the Family Smoking Prevention and Tobacco Control Act, over e-cigarette industry objections.
Read moreModerna is ready to seek emergency use authorization for the vaccine it has reported as over 94% effective in preventing Covid-19, the Massachusetts-based drugmaker said Monday.
Read moreResearchers who recently found asbestos in 15% of talc-based cosmetics samples analyzed in a small study say that current screening methods for the cancer-causing carcinogen are inadequate.
Read morePurdue Pharma pleaded guilty Tuesday to federal criminal charges related to the OxyContin manufacturer’s role in the nation’s deadly opioid crisis.
Read morePharmaceutical giant Pfizer and its partner BioNTech will forge ahead in their pursuit of emergency use authorization for their Covid-19 vaccine, a booster the company declared this week was 95% effective.
Read more